News

News and Press Releases
About the CF Foundation | Antibiotics | Infection Prevention and Control CF Foundation Invests Up to $4.85 Million in Aridis Pharmaceuticals for Testing of Anti-Infective

The investment will go toward finishing a Phase 2a clinical trial for an anti-infective to treat chronic infections in people with CF.

| 2 min read
Research | Infection Prevention and Control International Study Reports COVID-19 Outcomes in People With Cystic Fibrosis

Collaborative effort identifies 40 cases of COVID-19 across eight countries; outcomes for this high-risk population were reported in the Journal of Cystic Fibrosis

| 4 min read
Our Advocacy Work | Infection Prevention and Control | Germs Cystic Fibrosis Foundation Statement on COVID-19 Triage Plans

A cystic fibrosis diagnosis must not disqualify an individual from life-saving care.

| 2 min read
About the CF Foundation | Infection Prevention and Control Updated Infection Prevention and Control Guidelines for Cystic Fibrosis Now Published Online

A comprehensive, updated resource to assist the cystic fibrosis community with infection prevention and control practices is now available online. “Infection Prevention and Control Guideline for Cystic Fibrosis: 2013 Update” will also be published in the August print edition of Infection Control & Hospital Epidemiology, the official journal of the Society for Healthcare Epidemiology of America.

| 2 min read
About the CF Foundation | Infection Prevention and Control CF Foundation Updates Infection Prevention and Control Policy for All Foundation Events and Meetings

The Cystic Fibrosis Foundation recently updated its Infection Prevention and Control Policy for all Foundation events, meetings and offices to protect the health of people with cystic fibrosis.

| 2 min read